Article
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
The New England journal of medicine - 10 Oct 1996
Katzenstein D A, Hammer S M, Hughes M D, Gundacker H, Jackson J B, Fiscus S, Rasheed S, Elbeik T, Reichman R, Japour A, Merigan T C, Hirsch M S
Abstract excerpt
BACKGROUND: We studied measures of human immunodeficiency virus (HIV) replication, the viral phenotype, and immune function (CD4 cell counts) and the relation of changes in these indicators to clinical outcomes in a subgroup of patients in a controlled trial of early antiretroviral treatment for...
Topics
- Adult
- Antiviral Agents
- CD4 Lymphocyte Count
- Didanosine
- Disease Progression
- Drug Therapy, Combination
- Female
- HIV
- HIV Infections
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Phenotype